Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationBasic Clin. Pharmacol. Toxicol. 2015, 116 (3):201-11 Basic Clin. Pharmacol. Toxicol.
AbstractDrug utilization (DU) studies in inpatient settings at a national level are rarely conducted. The main objective of this study was to review the general information on hospital medicine management in Europe and to report on the availability and characteristics of nationwide administrative drug consumption databases. A secondary objective was to perform a review of published studies on hospital DU of a group of selected drugs, focusing on methodological characteristics (ATC/DDD). General information on hospital drug management was retrieved from several websites, nationwide administrative drug consumption databases and reports published by governmental organizations. A PubMed search was conducted using keywords related to the selected group of drugs AND 'hospital drug utilization'. The data sources for hospital DU information varied widely and included 14 databases from 25 reviewed countries. Bulgaria, Croatia, Denmark, Estonia, Finland, France, Hungary, Iceland, Latvia, Norway and Sweden obtain information on inpatient DU at a national level from wholesalers/manufacturers. In Belgium, Italy and Portugal, drugs dispensed to patients in hospitals are registered at a national level. Data are freely available online only for Denmark and Iceland. From the PubMed search, of a total of 868 retrieved studies, only 13 studies used the ATC/DDD methodology. Although the number of DDD/100 bed-days was used in four studies, other units of measure were also used. The type of information provided for the inpatient sector allowed primarily for conducting DU research at an aggregated data level. The existence of national administrative structures to monitor hospital DU would contribute to promoting the rational use of medicines and improving the safety and quality of prescribing.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to Basic & clinical pharmacology & toxicology
- Sources of European drug consumption data at a country level.
- Authors: Ferrer P, Ballarín E, Sabaté M, Laporte JR, Schoonen M, Rottenkolber M, Fortuny J, Hasford J, Tatt I, Ibáñez L
- Issue date: 2014 Oct
- The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014-2015.
- Authors: Potočnjak I, Likić R, Degoricija V, Nham E, Wettermark B
- Issue date: 2018 Dec
- Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting.
- Authors: Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, Weber R
- Issue date: 2008 Dec
- European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe.
- Authors: Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, Blix HS, Goossens H, ESAC Project Group.
- Issue date: 2011 Aug
- The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
- Authors: Calasan J, Mijatović V, Horvat O, Varga J, Sabo A, Stilinović N
- Issue date: 2011 Apr